Literature DB >> 4106490

The development of neutrophilic polymorphonuclear leukocytes in human bone marrow.

D F Bainton, J L Ullyot, M G Farquhar.   

Abstract

Neutrophilic leukocytes (PMN) and their precursors from normal human marrow and blood were examined by histochemical staining and by electron microscopy and cytochemistry in order to determine the origin and nature of their cytoplasmic granules. Human neutrophils contain two basic types of granules, azurophils and specifics, which differ in morphology, contents, and time of origin. Azurophils are large and may be spherical or ellipsoid, the latter with a crystalline inclusion. They are produced in the first secretory stage (promyelocyte), contain peroxidase and various lysosomal enzymes, and thus correspond to modified primary lysosomes. Specifics are smaller, may be spherical or elongated, and are formed during a later secretory stage (myelocyte). They lack lysosomal enzymes and contain alkaline phosphatase and basic protein; their contents remain largely undetermined. Specifics outnumber azurophils in the mature PMN because of reduction in numbers of azurophils per cell by cell division in the myelocyte stage. The findings indicate that the situation is basically the same as described previously in the rabbit, insofar as the origin, enzymic activity, and persistence in the mature cell of the two types (azurophil and specific) of granules are concerned. The main difference between PMN of the two species is in the morphology (size, shape, and density) of the granules, especially the azurophils.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4106490      PMCID: PMC2138991          DOI: 10.1084/jem.134.4.907

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  [Periodic structures in the eosinophil and neutrophil granulations of the polynuclear leukocytes of human blood].

Authors:  J Breton-Gorius
Journal:  Nouv Rev Fr Hematol       Date:  1966 Mar-Apr

2.  Myeloperoxidase of the leucocyte of normal human blood. 3. Isolation of the peroxidase granule.

Authors:  J Schultz; R Corlin; F Oddi; K Kaminker; W Jones
Journal:  Arch Biochem Biophys       Date:  1965-07       Impact factor: 4.013

Review 3.  Structure and function at the cellular level.

Authors:  G E Palade
Journal:  JAMA       Date:  1966-11-21       Impact factor: 56.272

4.  A method of preparing peripheral leucocytes for electron microscopy.

Authors:  D R Anderson
Journal:  J Ultrastruct Res       Date:  1965-10

5.  The cytochemical demonstration of lysosomal aryl sulfatase activity by light and electron microscopy.

Authors:  S Goldfischer
Journal:  J Histochem Cytochem       Date:  1965 Jul-Aug       Impact factor: 2.479

6.  [Electron microscopic studies on peroxidase and acid phosphatase reaction in human leukocytes (in normal and leukemic cells and on phagocytosis)].

Authors:  T Enomoto; T Kitani
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1966-08

7.  The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique.

Authors:  R C Graham; M J Karnovsky
Journal:  J Histochem Cytochem       Date:  1966-04       Impact factor: 2.479

8.  [Some observations on the cytochemistry and morphogenesis of the granulocytes in the rat bone marrow as revealed by electron microscopy].

Authors:  E Yamada; R Yamauchi
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1966-08

9.  Cell junctions in amphibian skin.

Authors:  M G Farquhar; G E Palade
Journal:  J Cell Biol       Date:  1965-07       Impact factor: 10.539

10.  Origin of granules in polymorphonuclear leukocytes. Two types derived from opposite faces of the Golgi complex in developing granulocytes.

Authors:  D F Bainton; M G Farquhar
Journal:  J Cell Biol       Date:  1966-02       Impact factor: 10.539

View more
  200 in total

1.  The proper study of mankind.

Authors:  W M Nauseef
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  A light and electron microscopic study of myelopoietic cells in the perihepatic subcapsular region of the liver in the adult aquatic newt, Notophthalmus viridescens.

Authors:  J A Hightower; J L Haar
Journal:  Cell Tissue Res       Date:  1975-05-27       Impact factor: 5.249

3.  Analysis of human neutrophil granule protein composition in chronic myeloid leukaemia by immuno-electron microscopy.

Authors:  H C Mutasa
Journal:  Cell Tissue Res       Date:  1989-10       Impact factor: 5.249

Review 4.  Defense of the bovine mammary gland by polymorphonuclear neutrophil leukocytes.

Authors:  Max Paape; Jalil Mehrzad; Xin Zhao; Johann Detilleux; Christian Burvenich
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

Review 5.  Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis.

Authors:  J P Uetrecht
Journal:  Drug Saf       Date:  1992       Impact factor: 5.606

6.  Protective role of D-amino acid oxidase against Staphylococcus aureus infection.

Authors:  Hideaki Nakamura; Jun Fang; Hiroshi Maeda
Journal:  Infect Immun       Date:  2012-01-23       Impact factor: 3.441

7.  Acquisition of peroxidase activity by rat alveolar macrophages during pulmonary inflammation.

Authors:  J Shellito; M Sniezek; M Warnock
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

8.  Human neutrophil gelatinase is a component of specific granules.

Authors:  M S Hibbs; D F Bainton
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

9.  Different glycosphingolipid composition in human neutrophil subcellular compartments.

Authors:  A Karlsson; H Miller-Podraza; P Johansson; K A Karlsson; C Dahlgren; S Teneberg
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

10.  The differential mobilization of human neutrophil granules. Effects of phorbol myristate acetate and ionophore A23187.

Authors:  D G Wright; D A Bralove; J I Gallin
Journal:  Am J Pathol       Date:  1977-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.